The good news is that you can choose options that have similar efficacy to semaglutide or are more effective for weight management and glycemic control
It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. CLICK HERE FOR MORE HEALTH STORIES This approval is for obesity management, not diabetes treatment, the expert emphasized
Research shows that people who used semaglutide had lower vitamin B12 levels (they also had bariatric surgery before using semaglutide), and another study concluded that people with obesity had lower B12 levels
Who qualifies: Typically, this program is available to people with c ommercial (non-government) insurance whose plans already cover Wegovy
Understanding the risk factors can help you and your doctor make better decisions about your treatment
1 NICE already recommends weight loss as a core treatment for osteoarthritis, and Wegovy now has trial evidence in that specific population